US Ophthalmic Drugs Market Size, Share, and COVID-19 Impact Analysis, By Drug Class (Anti-allergy, Anti-inflammatory, and Anti-VEGF Agents), By Disease (Dry Eye, Allergies, Glaucoma, Eye Infection, and Retinal Disorders), By Route of Administration (Topical, Local Ocular, and Systemic), and US Ophthalmic Drugs Market Insights, Industry Trend, Forecasts to 2033
Premium Report Details
Base Year:
2023
Tables & Figures:
110
Pages:
250
Countries covered:
1
Companies covered::
10
Forecast CAGR:
8.29 %
Connect with us
smartphone
smartphone
email
email
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we
also
use cookies to show you personalized ads? Learn
more and manage your cookies